Gsk (GSK) EBIT (2009 - 2026)
Gsk's EBIT came in at $3.72 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) EBIT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 8, 2026, Gsk reported EBIT of $4.01 billion; for the year ended Dec 31, 2025, it was $10.46 billion, up 103.5% from the prior year.
- EBIT carries a five-year compound annual growth rate of 6.4% (years ended Dec 2020 to Dec 2025).
- Going back by year, EBIT was $5.14 billion in the year ended Dec 31, 2024 (-38.7%), $8.39 billion in the year ended Dec 31, 2023 (+5.4%), $7.96 billion in the year ended Dec 31, 2022 (+32.8%) and $5.99 billion in the year ended Dec 31, 2021 (-21.9%).
- The figure for the quarter ended Sep 8, 2026 represents the highest quarterly EBIT since the quarter ended Dec 31, 2020.
- Year-over-year, EBIT increased in four of the last five quarters, with growth averaging 7.6%.
- The fastest year-over-year change in EBIT over five years came in the quarter ended Dec 31, 2022 (growth of 230.4%), and the weakest in the quarter ended Dec 31, 2021 (a decline of 93.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 645.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 645.35 Mn |
| Mar 31, 2026 | 3.09 Bn |
| Dec 31, 2025 | -3.45 Bn |
| Sep 30, 2025 | 3.50 Bn |
| Jun 30, 2025 | 2.70 Bn |
| Mar 31, 2025 | 2.79 Bn |
| Dec 31, 2024 | 893.32 Mn |
| Sep 30, 2024 | 245.57 Mn |
| Jun 30, 2024 | 2.08 Bn |
| Mar 31, 2024 | 1.89 Bn |
| Dec 31, 2023 | 711.18 Mn |
| Sep 30, 2023 | 2.47 Bn |
| Jun 30, 2023 | 2.68 Bn |
| Mar 31, 2023 | 2.53 Bn |
| Dec 31, 2022 | 2.19 Bn |
| Sep 30, 2022 | 1.40 Bn |
| Jun 30, 2022 | 1.36 Bn |
| Mar 31, 2022 | 3.08 Bn |
| Dec 31, 2021 | 663.22 Mn |
| Sep 30, 2021 | 1.90 Bn |
API Access
Gsk EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();